The science is now clear: oral pre-exposure prophylaxis (PrEP) with a coformulation of tenofovir disoproxil fumarate and emtricitabine (Truvada) significantly reduces the risk of HIV infection among individuals at high risk of HIV infection. The news that PrEP has shown consistent efficacy among those who take it as prescribed should be a cause for celebration, and galvanise action to ensure access to PrEP for those who could benefit the most.
17 April 2015 | The Lancet
Switching gears from a typical executive director's report to the Board during the Global Fund's 33rd meeting on 31 March, Mark Dybul reflected on the six trips he had made in the first quarter of 2015 that demonstrated what he said were the breadth and flexibility inherent in the new funding model.
02 April 2015 | Global Fund Observer
The situation with harm reduction in Serbia is getting increasingly alarming after withdrawal of the Global Fund. Three organizations doing HR programs in Serbia for more than a decade are struggling to maintain services. We want a different future for their beneficiaries. ""Please use your communication with donors to put Serbia back as eligible for funding the harm reduction programs - we keep knocking on closed doors. The EU is the biggest donor here and has no health programs whatsoever; as for other donors, we are ineligible whomever we approach, and keep losing on relevance to the calls,“ says Miodrag Atanasjevic, NGO Veza, Belgrade, Serbia.
02 April 2015 | Eurasian Harm Reduction Network
Men who have sex with men (MSM) and transgender people (TG) are not involved in strategic discussions around HIV in most nations of Eastern Europe and Central Asia (EECA). Lack of reliable epidemiological data, high stigma, and policies that restrict the access of MSM and TG to information on HIV preclude the two key populations from meaningfully participating in the country dialogue processes.
01 April 2015 | EATG
UNAIDS is holding its first round of virtual consultations to develop its 2016–2021 Strategy. From 23 March to 2 April, the consultation process will be open to everyone to share information, ideas and experiences on how to accelerate rights-based, evidence-informed action to Fast-Track the AIDS response.
26 March 2015 | UNAIDS
The Bill & Melinda Gates Foundation, which has distributed billions of dollars in grants to improve health and living conditions in developing countries, is increasingly expanding its tool kit, using some of its capital to invest directly in companies that could help advance its goals.
13 March 2015 | New York Times
The global HIV advocacy group AVAC has raised an alarm that global goals for HIV prevention may prove ineffectual due to their vagueness.
24 February 2015 | AIDSMeds
With an emphasis on reaching populations with the highest rates of HIV and the least access to prevention and treatment services, the new guidelines note that local civil society involvement is needed to inform and sustain effective outreach to neglected populations, and the guidelines establish procedures to ensure that involvement is sought and put to use.
16 February 2015 | Science Speaks
President Obama's proposed $4 trillion budget for fiscal year 2016 would increase funding for CDC's viral hepatitis and HIV prevention efforts, boost spending for HIV research, and allocate more to combat antibiotic resistance. But the plan would cut overall global health funding, including support for the Global Fund to Fight AIDS, Malaria, and Tuberculosis.
09 February 2015 | HIVandHepatitis.com
Bill Gates said he expects a pair of advances by 2030 that will eliminate most of the damage from AIDS. Improved treatment and the development of a vaccine to prevent new infections are the “two miracles” needed to help turn the tide, the billionaire said Friday at the World Economic Forum in Davos, Switzerland.
26 January 2015 | Bloomberg